Plasmin

DRUG3 trials

Sponsors

Bausch & Lomb Incorporated, Grifols Therapeutics LLC

Conditions

Acute Peripheral Arterial OcclusionVitreoretinal Traction Syndrome

Phase 1

A Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment (PVD)

TerminatedNCT00347646

Bausch & Lomb IncorporatedVitreoretinal Traction Syndrome

Start: 2006-09-30End: 2007-06-30Updated: 2019-06-21

Phase 2

Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment

TerminatedNCT00348439

Bausch & Lomb IncorporatedVitreoretinal Traction Syndrome

Start: 2006-04-30End: 2007-08-31Updated: 2019-06-21

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

CompletedNCT01222117

Grifols Therapeutics LLCAcute Peripheral Arterial Occlusion

Start: 2010-12-31End: 2016-01-31Updated: 2017-01-16

Related Papers

Phase 2, randomized, open-label study on catheter-directed thrombolysis with plasmin versus rtPA and placebo in acute peripheral arterial occlusion

Journal of Drug Assessment2019-01-012 citations